Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pediatric fever treatment

This article was originally published in The Tan Sheet

Executive Summary

Alternating acetaminophen (12.5 mg/kg) and ibuprofen (5 mg/kg) in young children is more effective for reducing fever than mono-therapy, a randomized, parallel-group trial in the February Archives of Pediatrics & Adolescent Medicine finds. The study was conducted in 464 children aged 6-36 months, with a follow-up period of 10 days. Children who received alternating doses every four hours for three days also received a lower mean number of doses per child in days 1-3, required 22.6% fewer doses from day 1-2 and had fewer fever recurrences on days five and ten, Michael Sarrell, MD, et al., Tel Aviv University, report. Difference in fever reduction between acetaminophen and ibuprofen groups was not statistically significant. Participants "may have been more seriously ill than most of the children who receive over-the-counter antipyretics" since they were recruited at presentation for treatment, the authors note...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099114

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel